WATSON 152 8 mg Pill - white capsule/oblong, 19mm
Generic Name: silodosin
Pill with imprint WATSON 152 8 mg is White, Capsule/Oblong and has been identified as Rapaflo 8 mg. It is supplied by Allergan, Inc.
Rapaflo is used in the treatment of Benign Prostatic Hyperplasia and belongs to the drug class alpha-adrenoreceptor antagonists. There is no proven risk in humans during pregnancy. Rapaflo 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 152 8 mg
Rapaflo
- Generic Name
- silodosin
- Imprint
- WATSON 152 8 mg
- Strength
- 8 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alpha-adrenoreceptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Allergan, Inc.
- National Drug Code (NDC)
- 52544-0152 (Discontinued)
More about Rapaflo (silodosin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (99)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: alpha-adrenoreceptor antagonists
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
